← SynDRA
AZD-7648
SynDRA canonical compound SYN0039871 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
| Primary target(s) | PRKDC |
| Mechanism of action | dna protein kinase inhibitor |
| Indication | melanoma |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
- PIK3CA INHIBITOR
- PIK3CG INHIBITOR
- PRKDC INHIBITOR
- dna protein kinase inhibitor
Drug classes
- Protein Kinase Inhibitors
Cross-references
Synonyms
- AZD 7648
- AZD7648
- 7-METHYL-2-({7-METHYL-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YL}AMINO)-9-(OXAN-4-YL)-8,9-DIHYDRO-7H-PURIN-8-ONE
- UNII-97A09L5JCK
- 97A09L5JCK
- 7-methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7,9-dihydro-8H-purin-8-one
- 7-Methyl-2-((7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-7H-purin-8(9H)-one
- 7-methyl-2-[(7-methyl-[1,2,4]triazolo[1,5-a]pyridin-6-yl)amino]-9-(oxan-4-yl)purin-8-one
- CHEMBL4439259
- SCHEMBL20299477
- GTPL10601
- US10407446, Example 3
- BDBM413450
- BCP30676
- EX-A2988
- AZD 7648;AZD7648
- MFCD32062688
- NSC817043
- s8843
- ZB1555
- NSC-817043
- SB23233
- compound 16 [PMID: 31851518]
- AC-31586
- BS-16016
- HY-111783
- CS-0091859
- CN1C(=O)N(C2CCOCC2)C2=NC(NC3=CN4N=CN=C4C=C3C)=NC=C12
- 7-Methyl-2-((7-methyl(1,2,4)triazolo(1,5- a)pyridin-6-yl)amino)-9-(tetrahydro-2H-pyran- 4-yl)-7,9-dihydro-8H-purin-8-one
- 8H-Purin-8-one, 7,9-dihydro-7-methyl-2-((7- methyl(1,2,4)triazolo(1,5-a)pyridin-6- yl)amino)-9-(tetrahydro-2H-pyran-4-yl)-
- RefChem:116017
- DNA-PK inhibitor AZD7648
- DNA-dependent Protein Kinase Inhibitor AZD7648
- C18H20N8O2
- AZD-?7648
- orb1300051
- SCHEMBL29360552
- GLXC-21618
Look up AZD-7648 in the interactive SynDRA portal →